Israel Englander’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.12M | Sell |
30,340
-277,582
| -90% | -$16.3M | ﹤0.01% | 3427 |
|
|
2026
Q1 | $11.8M | Sell |
307,922
-132,024
| -30% | -$4.18M | ﹤0.01% | 2021 |
|
|
2025
Q4 | $9.6M | Buy |
439,946
+404,838
| +1,153% | +$8.41M | ﹤0.01% | 2310 |
|
|
2025
Q3 | $754K | Sell |
35,108
-22,453
| -39% | -$503K | ﹤0.01% | 4829 |
|
|
2025
Q2 | $1.48M | Sell |
57,561
-58,912
| -51% | -$1.72M | ﹤0.01% | 4129 |
|
|
2025
Q1 | $4.26M | Buy |
116,473
+39,143
| +51% | +$1.35M | ﹤0.01% | 3021 |
|
|
2024
Q4 | $2.37M | Buy |
77,330
+13,017
| +20% | +$433K | ﹤0.01% | 3487 |
|
|
2024
Q3 | $2.42M | Buy |
64,313
+48,639
| +310% | +$1.87M | ﹤0.01% | 3535 |
|
|
2024
Q2 | $621K | Buy |
15,674
+4,105
| +35% | +$133K | ﹤0.01% | 4452 |
|
|
2024
Q1 | $389K | Sell |
11,569
-15,549
| -57% | -$523K | ﹤0.01% | 4970 |
|
|
2023
Q4 | $904K | Sell |
27,118
-53,942
| -67% | -$1.74M | ﹤0.01% | 4239 |
|
|
2023
Q3 | $2.54M | Buy |
81,060
+69,698
| +613% | +$2.19M | ﹤0.01% | 3338 |
|
|
2023
Q2 | $360K | Buy |
+11,362
| New | +$367K | ﹤0.01% | 4767 |
|
|
2022
Q2 | – | Sell |
-35,963
| Closed | -$2.08M | – | 6950 |
|
|
2022
Q1 | $2.08M | Sell |
35,963
-9,751
| -21% | -$533K | ﹤0.01% | 3839 |
|
|
2021
Q4 | $2.69M | Sell |
45,714
-2,679
| -6% | -$163K | ﹤0.01% | 3499 |
|
|
2021
Q3 | $2.94M | Buy |
48,393
+19,984
| +70% | +$1.17M | ﹤0.01% | 3467 |
|
|
2021
Q2 | $1.7M | Buy |
+28,409
| New | +$1.42M | ﹤0.01% | 4149 |
|
|
2020
Q3 | – | Sell |
-22,839
| Closed | -$1.04M | – | 4425 |
|
|
2020
Q2 | $1.04M | Buy |
22,839
+17,826
| +356% | +$911K | ﹤0.01% | 2970 |
|
|
2020
Q1 | $229K | Buy |
+5,013
| New | +$227K | ﹤0.01% | 3315 |
|
|
2019
Q3 | – | Sell |
-146,426
| Closed | -$6.88M | – | 4140 |
|
|
2019
Q2 | $6.88M | Buy |
146,426
+52,160
| +55% | +$2.2M | 0.01% | 1539 |
|
|
2019
Q1 | $3.31M | Buy |
94,266
+81,162
| +619% | +$3.19M | 0.01% | 2052 |
|
|
2018
Q4 | $490K | Sell |
13,104
-48,376
| -79% | -$1.89M | ﹤0.01% | 2984 |
|
|
2018
Q3 | $2.08M | Buy |
+61,480
| New | +$1.8M | ﹤0.01% | 2403 |
|
|
2016
Q3 | – | Sell |
-21,585
| Closed | -$462K | – | 3255 |
|
|
2016
Q2 | $462K | Buy |
+21,585
| New | +$680K | ﹤0.01% | 2524 |
|
|
2015
Q2 | – | Sell |
-12,143
| Closed | -$607K | – | 3299 |
|
|
2015
Q1 | $607K | Buy |
+12,143
| New | +$590K | ﹤0.01% | 2635 |
|
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
Israel Englander's ATEX Position: Q2 2026 in Review
Israel Englander reduced its Anterix (ATEX) stake by 90% in Q2 2026, selling an estimated $16.3M and leaving 30,340 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3427.
Israel Englander first reported a position in ATEX in Q1 2015 and has held it in 25 quarters since. The position peaked at $11.8M in Q1 2026. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- Israel Englander held 30,340 shares of Anterix worth $3.12M as of Q2 2026.
- Israel Englander sold 277,582 Anterix shares in Q2 2026, an estimated $16.3M.
- Anterix made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3427 holding.
- Israel Englander first reported a position in Anterix in Q1 2015 and has held it in 25 quarters since.
- Israel Englander's Anterix position peaked at $11.8M in Q1 2026.
- 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.